Skip to playerSkip to main content
  • 5 hours ago
A parliamentary committee is raising serious concerns about how special drug import licences were issued, questioning whether legal safeguards were bypassed and whether authority meant for the Health Minister was effectively shifted elsewhere.
Transcript
00:00The power to grant special import licenses for drugs is by law reserved solely for the Minister of Health.
00:07So the Minister has the ultimate regulatory power in granting registration, in granting import permit for all three classes of
00:26drugs.
00:27But information emerging from Internal Health Ministry emails paint a different picture.
00:33Data linked to one chief medical officer shows what the Public Administration Appropriations Committee describes as an unusually high volume
00:43of requests for special approvals.
00:46Dr. Roshan Parasram, 2,440 emails concerning special permission.
00:54Dr. Harry Smith, 4, Dr. Roger Ramjohn, 0, Mr. Brian Amor, 6.
01:03Committee Chairman Jagdao Singh is now questioning whether that authority was effectively transferred and if so, by whom.
01:10It appears to me there's a curious confluence of circumstances that from a very rarely used power, a literal administrative
01:23mushroom cloud developed by 2017.
01:26Special import licenses are intended for urgent life-saving drugs, not routine items.
01:32There is evidence that special permission was used to import Barajan Redoxal and Philips Milikov Magnesia.
01:41And this three.
01:42And this three.
01:44Correct.
01:44Amongst others.
01:45It's just too numerous to go through.
01:48Chairman Singh says the situation raises deeper concerns, particularly when special permits are used for drugs already registered in Trinidad
01:56and Tobago.
01:57It makes it worse because it would mean that the entire regulatory and scientific oversight process is being avoided by
02:12the special permit.
02:14And the practice may not only be questionable, but previously flagged as unlawful.
02:21I remember Ms. Rob Chan, who is a former legal advisor, at that point in time, commented to the DAC,
02:29because she was a member of the DAC at that point in time, that special permission was illegal and ultra
02:34-virus to the Food and Drug Act.
02:37Hence, all possible avenues to get the product re-registered was done.
02:43Public servants also testified that instructions were given to fast-track the process.
02:49Yesterday, I was in office at the time, and I heard the rewards, and I saw it myself, that what
02:54was done, in a particular manner, that's not in line with the regulations of the Food and Drug Act.
03:02The committee is expected to continue its examination into how and why these approvals were granted and whether established laws
03:10were bypassed in the process.
03:13Urvishitawari, Ruknarain, TV6 News.
03:17Urvishitawari, Ruknarain, TV6 News.
03:18Urvishitawari, Ruknarain, TV6 News.
03:18Urvishitawari, Ruknarain, TV6 News.
03:18Urvishitawari, Ruknarain, TV6 News.
Comments